X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
Other Certificates
0
Other Suppliers
0
USA (Orange Book)
Europe
0
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
0
Annual Reports
0
85
PharmaCompass offers a list of Glycine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Glycine manufacturer or Glycine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Glycine manufacturer or Glycine supplier.
PharmaCompass also assists you with knowing the Glycine API Price utilized in the formulation of products. Glycine API Price is not always fixed or binding as the Glycine Price is obtained through a variety of data sources. The Glycine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Glycine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Glycine, including repackagers and relabelers. The FDA regulates Glycine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Glycine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Glycine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Glycine supplier is an individual or a company that provides Glycine active pharmaceutical ingredient (API) or Glycine finished formulations upon request. The Glycine suppliers may include Glycine API manufacturers, exporters, distributors and traders.
click here to find a list of Glycine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Glycine DMF (Drug Master File) is a document detailing the whole manufacturing process of Glycine active pharmaceutical ingredient (API) in detail. Different forms of Glycine DMFs exist exist since differing nations have different regulations, such as Glycine USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Glycine DMF submitted to regulatory agencies in the US is known as a USDMF. Glycine USDMF includes data on Glycine's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Glycine USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Glycine suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Glycine Drug Master File in Japan (Glycine JDMF) empowers Glycine API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Glycine JDMF during the approval evaluation for pharmaceutical products. At the time of Glycine JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Glycine suppliers with JDMF on PharmaCompass.
A Glycine CEP of the European Pharmacopoeia monograph is often referred to as a Glycine Certificate of Suitability (COS). The purpose of a Glycine CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Glycine EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Glycine to their clients by showing that a Glycine CEP has been issued for it. The manufacturer submits a Glycine CEP (COS) as part of the market authorization procedure, and it takes on the role of a Glycine CEP holder for the record. Additionally, the data presented in the Glycine CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Glycine DMF.
A Glycine CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Glycine CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Glycine suppliers with CEP (COS) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Glycine as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Glycine API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Glycine as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Glycine and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Glycine NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Glycine suppliers with NDC on PharmaCompass.
Glycine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Glycine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Glycine GMP manufacturer or Glycine GMP API supplier for your needs.
A Glycine CoA (Certificate of Analysis) is a formal document that attests to Glycine's compliance with Glycine specifications and serves as a tool for batch-level quality control.
Glycine CoA mostly includes findings from lab analyses of a specific batch. For each Glycine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Glycine may be tested according to a variety of international standards, such as European Pharmacopoeia (Glycine EP), Glycine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Glycine USP).
Market Place
